About this trial
The purpose of this study is to establish the clinical efficacy of Mentalizing Imagery Therapy (MIT) for Alzheimer's Disease and Related Disorders (ADRD) family caregivers in terms of mentalizing and elder mistreatment (EM) risk factors of stress, depression, and suicidality and to identify the mechanistic impacts of MIT on ADRD family caregivers' mental health,including stress, depression, and suicidality.
Eligibility criteria
Qualifiers
Primary family ADRD caregivers
Recruited nationally.
Caring for someone aged 60 or older
Provide at least 8 hours of care weekly
Disqualifiers
Active psychosis or mania
A suicide attempt in the last 6 months or current suicidal intent
Self-reported memory or cognitive complaints
Unstable medical conditions or planned major surgery
Trial design
Treatments tested in this trial
- Mentalizing Imagery Therapy
- Mindfulness Exercises.
Treatment groups
Sponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
National Institute on Aging (NIA)
Collaborator